WSAUA SCIENTIFIC OUTLINE OF 86TH ANNUAL MEETING
Sunday, October 24, 2010        
Poster Session I: Prostate 1 - 7:30 AM - 9:30 AM      
Objectives: 1) Evaluate the significance of surgical margins. 2) Compare treatment options for localized prostate cancer. 3) Analyze the indications for pelvic lymph node dissection in the treatment of prostate cancer.
Program Planner: Paul Andrews, M.D.        
Poster Judges/Poster Planner: Paul Andrews, M.D. / Immediate Past President: Steven Stewart, M.D., President Elect: Stephen Chinn, M.D.
Moderators: Joseph Presti, Jr., M.D., Matthew R. Cooperberg, M.D., MPH  
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Poster Session I - Prostate 1 1 X 1st Place JFM Essay 2 J. Kellogg Parsons, M.D., MHS A Prospective Study of Serum Dihydrotestosterone and Subsequent Risk of Benign Prostatic Hyperplasia in Community Dwelling Men: The Rancho Bernardo Study.
Poster Session I - Prostate 1 2 X   2 Pejvak Sassani M.D. A Prospective Comparison of Outcomes in Men Treated for Low to Intermediate Risk Prostate Cancer:  Erectile Function and Biochemical Control Following Nerve Sparing Prostatectomy or Seed Brachytherapy.
Poster Session I - Prostate 1 3 X   2 Jared M Whitson, M.D. The Presence of Primary Pattern 4/5 and Primary Pattern 3 Predicts for Downgrading at Radical Prostatectomy.
Poster Session I - Prostate 1 4 X   2 Ryan P. Dorin, M.D. Prognostic Impact of Histopathologic Characteristics of Positive Apical Margins in Clinically Localized Prostate Cancer.
Poster Session I - Prostate 1 5 X   2 Megan Melnyk, B.SC., MSc. M.D. Radical Prostatectomy for High Risk Clinically Localised Prostate Cancer: A Prospective Single Institution Series.
Poster Session I - Prostate 1 6 X   2 Tin Ngo, M.D Smoking and Adverse Features at Radical Prostatectomy.
Poster Session I - Prostate 1 7 X   2 J. Kellogg Parsons, M.D Obesity and Prostate Enlargement in Men with Localized Prostate Cancer.
Poster Session I - Prostate 1 8 X   2 Osamu Ukimura, M.D. Virtual Navigation TRUS-guided Focal Ablation of Prostate Cancer: An Experimental Study.
Poster Session I - Prostate 1 9 X   2 Ryan P. Kopp, M.D. Prostate Atypia: Clinical and Pathologic Variables Associated with Cancer Diagnosis on Repeat Biopsy.
Poster Session I - Prostate 1 10 X   2 Rafael Nuñez-Nateras M.D. Effect of the Simultaneous Blockade of Androgen and Estrogen Receptors on Prostate Cancer: Preliminary Results.
Poster Session I - Prostate 1 11 X   2 Adam Reese, M.D. Inaccuracies in Assignment of Clinical Stage for Localized Prostate Cancer.
Poster Session I - Prostate 1 12 X   2 Dan Lewinshtein, M.D. Can Digital Rectal Examination Predict Where a Cancer Will Be in the Prostate?
Poster Session I - Prostate 1 13 X   2 CPT. Patrick S. McDonough, M.D. The Impact of Prostate Gland Size on the Predictive Accuracy of Standard Pre-Treatment Prognostic Models.
Poster Session I - Prostate 1 14 X No ppt received 2 Jennifer Linehan, M.D. Lymph Node Yield of Pelvic Lymphadenectomy During Robotic Assisted Laparoscopic Prostatectomy: Large Single Instutional Series
Poster Session I - Prostate 1 15 X No ppt received 2 James Porter, M.D. Standard vs. Extended Pelvic Lymph Node Dissection During Robotic Prostatectomy.
Poster Session I - Prostate 1 16 X   2 Andrew J. Hung, M.D. Robotically Manipulated Real-Time Transrectal Ultrasound during Robotic-assisted Laparoscopic Radical Prostatectomy: A Pilot Study.
Poster Session I - Prostate 1 17 X   2 Ryan P. Dorin, M.D. Adjuvant Radiotherapy Does Not Improve Outcomes in Radical Prostatectomy Patients  With an Isolated Positive Apical Margin.
Poster Session I - Prostate 1 18 X   2 Osamu Ukimura, M.D. Re-Targeting of Prostate Biopsy Sites Using GPS-guided TRUS/MR Image Fusion: Pilot Study.
Poster Session I - Prostate 1 19 X   2 Winifred Adams, M.D. Morbidity and Mortality of Advanced Prostate Cancer with Presenting PSA Over 100ng/mL: A County Hospital Population.
Poster Session I - Prostate 1 20 X   2 Douglas O. Chinn, M.D. High Intensity Focused Ultrasound for Primary Treatment of Localized Prostate Cancer: Early Experience with the Ablatherm HIFU® Device.
Poster Session I - Prostate 1 21 X   2 J. Kellogg Parsons, M.D Prostate Cancer and Lower Urinary Tract Symptoms in Community Dwelling Older Men.
Poster Session I - Prostate 1 22 X   2 Jonathan N. Warner, M.D. A Multi-Institutional Study of the Effects of Medical Therapy for Lower Urinary Symptoms on the Perioperative Outcomes of Holmium Laser Enucleation of the Prostate (HoLEP).
Poster Session I - Prostate 1 23 X   2 Jeffrey M. Woldrich, M.D. Comparison of Outcomes of Laser Vaporization of the Prostate in Men with and without Urinary Retention.
Poster Session I - Prostate 1 24 X   2 Cory S. Bates, M.D. The Impact of the AUA Symptom Index Format on the Accurate Assessment of Nocturia.
Poster Session I - Prostate 1 25 X No ppt received 2 Jennifer Linehan, M.D. Positive Surgical Margins At The Apex After Robotic-Assisted Laparoscopic Radical Prostatectomy: Outcomes Of Dorsal Venous Complex Endoscopic Stapling Versus Suture Ligature.
Poster Session I - Prostate 1 26 X   2 Michael A. Liss, M.D. Prevalence and Significance of Fluoroquinolone-Resistant Escherichia coli in Patients Undergoing Transrectal Ultrasound Guided Prostate Needle Biopsy.
Poster Session I - Prostate 1 27 X Needs to resubmit abst. 2 Bruce Lowe, M.D. Open vs. Robotoc Prostatectomy for Cancer, A Comparative Analysis of Outcomes.
Sunday, October 24, 2010 27          
DVD Surgi-Session #1 - 7:30 AM - 11:00 AM 28          
Objectives: 1) Describe minimally invasive approaches to treatment of renal masses. 2) Review general concepts related to NOTES and LESS surgeries in urology. 3) Compare robotic and laparoscopic techniques for renal surgery.
Program Planner: Chris Amling, M.D.        
Moderators: Ithaar Derweesh, M.D., Michael Conlin, M.D.      
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
DVD Surgi-Session #1 28 X No ppt /DVD received 7 James Porter, M.D. Nerve Sparing Robotic Retroperitoneal Lymph Node Dissection for Stage I NSGCT.
DVD Surgi-Session #1 29 X   8 Chris M. Whelan, M.D. Technique of Robotic Assisted Laparoscopic Retroperitoneal Lymphadenectomy.
DVD Surgi-Session #1 30 X No ppt /DVD received 8 Clayton S. Lau, M.D. Da Vinci Retroperitoneal Lymph Node Dissection for Stage 1 Testis Cancer with the Dual Console Da Vinci Si.
DVD Surgi-Session #1 31 X No ppt /DVD received 8 James Porter, M.D. The Technique of Retroperitoneal Robotic Partial Nephrectomy.
DVD Surgi-Session #1 32 X   8.25 Manuel S. Eisenberg, M.D. "Zero Ischemia" Hypotensive Laparoscopic Partial Nephrectomy.
DVD Surgi-Session #1 33 X No ppt /DVD received 8 Chris M. Whelan, M.D. Technique of Robotic Assisted Partial Nephrectomy for Multiple Renal Lesions.
DVD Surgi-Session #1 34 X No ppt /DVD received 6 Andre Berger, M.D. Laparoscopic Interaortocaval Metastasectomy for RCC.
DVD Surgi-Session #1 35 X   8 Manuel S. Eisenberg, M.D. A Laparoscopic Approach for Management of a Left Renal Cell Carcinoma with Renal Vein Thrombus.
DVD Surgi-Session #1 36 X No ppt /DVD received 8 Ashok J. Kar, M.D. Laproscopic Excision of Large Retroperitoneal Mass.
DVD Surgi-Session #1 37 X   8 Mukul Patil, M.D. Contemporary Management of the Inferior Vena Cava Tumor Thrombus.
DVD Surgi-Session #1 38 X   7 Ryan Kopp, M.D. Laparoendoscopic Single Site Surgery (LESS) Left Partial Nephrectomy Utilizing Non-Ischemic Technique with the Laparoscopic HABIB 4X™ Bipolar Radiofrequency Coagulator.
DVD Surgi-Session #1 39 X   7 Ryan Kopp, M.D. Laparo-Endoscopic Single Site Surgery (LESS) Left Radical Nephrectomy with Renal Vein Thrombectomy.
DVD Surgi-Session #1 40 X No ppt /DVD received 6 Albert A. Mikhail, M.D. Intracorporeal Retraction For Single Port Transumbilical Laparoscopic Nephrectomy.
DVD Surgi-Session #1 41 X No ppt /DVD received 8 Clayton S. Lau, M.D. Technique of Single Incision Robotic Assisted Laparoscopic Nephrectomy.
DVD Surgi-Session #1 42 X No ppt /DVD received 6 Albert A. Mikhail, M.D. Synchronous Bilateral Partial Nephrectomy Via Single Site Transumbilcial Surgical Technique.
DVD Surgi-Session #1 43 X   5.5 Manuel S. Eisenberg, M.D. Pediatric LaparoEndoscopic Single Site (LESS) Nephrectomy.
DVD Surgi-Session #1 44 X   6 Ryan Kopp, M.D. Feasibility of Transrectal Natural Orifice Transluminal Endoscopic Surgery (NOTES) Nephrectomy in the Porcine Model.
DVD Surgi-Session #1 45 X No ppt /DVD received 5 Gene Huang, M.D. Transureteral NOTES Nephrectomy Video: A Feasibility Study in the Porcine Model.
DVD Surgi-Session #1 46 X   7 Ryan Kopp, M.D. Feasibility of Transvaginal Natural Orifice Transluminal Endoscopic Surgery (NOTES) Partial Nephrectomy Utilizing the HABIB 4X™  Bipolar Radiofrequency Coagulator in the Porcine Model.
DVD Surgi-Session #1 47 X No ppt /DVD received 5 Ryan Bowman, M.D. Stapling Device Failure During Hand-assisted Donor Nephrectomy Managed Without Open Conversion.
DVD Surgi-Session #1 48 X No ppt /DVD received 5 Monish Aron, M.D. Right Renal Vein Injury During Single Port Laparoscopic Adrenalectomy.
DVD Surgi-Session #2 - 7:30 AM - 11:00 AM      
Objectives: 1) Discuss the technique of extended lymph node dissection for prostate cancer. 2) List reconstructive urology procedures performed using minimally invasive approaches. 3) Review technical aspects of urinary incontinence surgery.
Program Planner: Chris Amling, M.D.        
Moderators: Brian Auge, M.D., Maxwell Meng, M.D.      
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
DVD Surgi-Session #2 49 X No ppt /DVD received 8 Chong H. Choe, M.D The Use of EnSeal® in Nerve Sparing Robotic Prostatectomy.
DVD Surgi-Session #2 50 X No ppt /DVD received 8 James Porter, M.D. The Technique of Extended Pelvic Lymph Node Dissection During Robotic Prostatectomy
DVD Surgi-Session #2 51 X No ppt /DVD received 8 Sean Stroup, M.D. Video: Robotic Assisted Extended Pelvic Lymph Node Dissection During Prostatectomy for High Risk Prostate Cancer.
DVD Surgi-Session #2 52 X No ppt /DVD received 8 Erik P. Castle, M.D. Robot Assisted Pelvic Lymphadenectomy: Obturator, Standard and Extended.
DVD Surgi-Session #2 53 X No ppt /DVD received 7 Andre Berger, M.D. Robotic Laparoscopic Radical Cystectomy with Extended Lymph Node Dissection and Ileal Neobladder- The USC Experience.
DVD Surgi-Session #2 54 X No ppt /DVD received 6 James Porter, M.D. Remote Proctoring Using the Davinci Connect System.
DVD Surgi-Session #2 55 X   10 William Sohn, M.D. Button TURP: The Pursuit of the Optimal Technique.
DVD Surgi-Session #2 56 X   7 Mukul B. Patil, M.D. Technique for Robotic-Assisted Laparoscopic Extravesical Ureteral Reimplantation in Children.
DVD Surgi-Session #2 57 X   7 Jason Kim, M.D. Robotic-Assisted Laparoscopic Augmentation Cystoplasty.
DVD Surgi-Session #2 58 X No ppt /DVD received 8 Chris M. Whelan, M.D. Technique of Robotic Assisted Distal Ureterectomy and Psoas Hitch Reimplantation.
DVD Surgi-Session #2 59 X   8 Jason M. Durbin, D.O. Retroperitoneal Robotic-Assisted Laparoscopic Reimplantation of a Ureter into an Ileal Conduit.
DVD Surgi-Session #2 60 X No ppt /DVD received 6 Jeremy Blumberg, M.D Transumbilical Dismembered Pyeloplasty.
DVD Surgi-Session #2 61 X   7 Leah Y. Nakamura, M.D. Natural Orifice Transurethral Fistulotomy, Closure and Excision of A Fistulous Tract
DVD Surgi-Session #2 62 X   7 Polina Reyblat, M.D. Urethral Reconstruction of Complicated Intractable Posterior Urethral Strictures.
DVD Surgi-Session #2 63 X No ppt /DVD received 8 Chong Choe, M.D. A Technique for Vasoepididymostomy.
DVD Surgi-Session #2 64 X No ppt /DVD received 8 Chong Choe, M.D. The Feasibility of Robotic Vasovasostomy.
DVD Surgi-Session #2 65 X Emailed DVD-will bring dvd to mtg 7 Pejvak Sassani, M.D. New Surgical Technique in Placement of Ventral Urethral Elevation Sling System in a Male Patient with Urinary Incontinence.
DVD Surgi-Session #2 66 X No ppt /DVD received 8 Gwen M. Grimsby, M.D. Video - The Transobturator Male Sling - Technique and A Review of Our Initial Experience.
DVD Surgi-Session #2 67 X No ppt /DVD received 6 Jeremy M. Blumberg, M.D. Transcorporal Artificial Urinary Sphincter Placement is Feasible in the Challenging Urethra: DVD Presentation.
Sunday, October 24, 2010        
Poster Session II:Bladder, Testes, Urethra - 9:30 AM - 11:30 AM    
Objectives: 1) Compare treatment options for female urinary incontinence. 2) Analyze and compare the effects of treatment data for bladder cancer.  3) Access factors influencing recurrent bladder cancer after cystectomy.
Program Planner: Paul Andrews, M.D.        
Moderators: Atreya Dash, M.D., Anthony Stone, M.D.      
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Poster Session II - Bladder, Testes, Urethra 68 X   2 Craig V. Comiter, M.D A New Quadratic Sling for Male Stress Urinary Incontinence.
Poster Session II - Bladder, Testes, Urethra 69 X   2 Michael G. Oefelein, M.D Does Trospium Chloride Cross the Blood-Brain Barrier in Older Adults with Overactive Bladder? Results of the SMART Trial.
Poster Session II - Bladder, Testes, Urethra 70 X No ppt received 2 Jason Kim, M.D. Comparison Of Short and Long Term Outcomes in a Patient Population Undergoing Retropubic Mid-Urethral Sling Placement.
Poster Session II - Bladder, Testes, Urethra 71 X   2 Peter K. Sand, M.D. Does the Severity of Incontinence Affect the Efficacy of Oxybutynin Topical Gel (OTG) in Improving Continence?
Poster Session II - Bladder, Testes, Urethra 72 X   2 Gwen M. Grimsby, M.D. A Comparison of Midurethral Sling Outcomes With and Without Concomitant Prolapse Repair.
Poster Session II - Bladder, Testes, Urethra 73 X   2 Brian R. Hu, M.D. Indications and Outcomes of Urinary Diversion for Intractable Incontinence.
Poster Session II - Bladder, Testes, Urethra 74 X   2 Siamak Daneshmand, M.D. Adjuvant Surgery In Patients Undergoing Post-Chemotherapy Retroperitoneal Lymph Node Dissection.
Poster Session II - Bladder, Testes, Urethra 75 X   2 Dan Lewinshtein, M.D. Risk of Secondary Malignancy in Patients with Testicular Cancer is Increased with Radiotherapy.
Poster Session II - Bladder, Testes, Urethra 76 X No ppt received 2 Alan I. So, M.D. The Importance of Integrin-linked kinase in the Regulation of Bladder Cancer Invasion.
Poster Session II - Bladder, Testes, Urethra 77 X No ppt received 2 Mark L. Gonzalgo, M.D., Ph.D. Inhibition of Bladder Cancer Cell Growth by Treatment with Synthetically-Derived Anti-Cancer Peptoids.
Poster Session II - Bladder, Testes, Urethra 78 X   2 Anne Schuckman, M.D. Squamous Cell Penile Cancer at LAC+USC Medical Center: Experience From 1999-2009.
Poster Session II - Bladder, Testes, Urethra 79 X   2 Siamak Daneshmand, M.D. Does Body Mass Index Influence Choice of Urinary Diversion?
Poster Session II - Bladder, Testes, Urethra 80 X   2 J. Kellogg Parsons, M.D. Prevalence of Treatment for LUTS in Community Dwelling Older Men.
Poster Session II - Bladder, Testes, Urethra 81 X   2 Maurice M. Garcia, M.D. Un-drained Bladder Urine in Catheterized Patients: A Likely Risk Factor For Catheter-Associated UTI, Which is Easily Detected on CT Scan of the Pelvis.
Poster Session II - Bladder, Testes, Urethra 82 X   2 Howard Jung, M.D. Association of Hematuria on Microscopic Urinalysis and Risk of Urinary Tract Cancer Development.
Poster Session II - Bladder, Testes, Urethra 83 X   2 Dan Lewinshtein, M.D. Impact of Age, Comorbidity, and Type of Urinary Diversion on Hospital Stay and Cost in Radical Cystectomy Patients.
Poster Session II - Bladder, Testes, Urethra 84 X   2 Michael B. Taylor, M.D. An Analysis of the Management and Acute Complications Associated With Bladder Injury From All Designated Trauma 1 Hospitals in Utah.
Poster Session II - Bladder, Testes, Urethra 85 X   2 Jordan A Siegel, M.D. 11 Year Experience Using Ventral and Dorsal Buccal Grafting for One-Stage Repair of Long Obliterative Urethral Strictures.
Poster Session II - Bladder, Testes, Urethra 86 X   2 Anne Schuckman, M.D. Impact of Dose Density of Adjuvant Chemotherapy for Locally Advanced Urothelial Carcinoma After Cystectomy.
Poster Session II - Bladder, Testes, Urethra 87 X   2 Mehran Movassaghi, M.D., MBA Positron Emission Tomography for Predicting Mestastatic Disease in Bladder Carcinoma Patients Undergoing Radical Cystectomy with Extended Lymphadenectomy.
Poster Session II - Bladder, Testes, Urethra 88 X   2 Pascal Zehnder, M.D. Meticulous Extended Lymph Node Dissection During Radical Cystectomy Allows For Recurrence Risk Stratification According to Total Nodal Yield and Positive Nodes.
Poster Session II - Bladder, Testes, Urethra 89 X   2 Anirban P. Mitra, M.D., Ph.D. Impact of Smoking Habits on Patient Outcome Following Radical Cystectomy.
Poster Session II - Bladder, Testes, Urethra 90 X   2 Stephen Lieberman, M.D. Pilot Study to Assess Recruitment Strategies for TCCA Screening Using UA and NMP 22 in a High-Risk Population.
Poster Session II - Bladder, Testes, Urethra 91 X   2 Polina Reyblat, M.D. Management of Intractable Posterior Urethra/ Bladder Neck Contracture and Urinary Incontinence: Long Term Evaluation
Poster Session II - Bladder, Testes, Urethra 92 X   2 Anirban P. Mitra, M.D., Ph.D. Factors Predictive of Patient Outcome Following Bladder Cancer Recurrence After Radical Cystectomy.
Sunday, October 24, 2010        
Health Policy Forum - 11:00 AM - 2:00 PM
Objectives: 1) Discuss AUA, State and National Updates 2) Describe the Healthcare Delivery System in the USA 3) Assess managing medicare and commercial contracts.
Program Planner: Jeffrey Kaufman, M.D., AUA Health Policy Chairman & Past Pres. CUA & AACU / Eugene Rhee, M.D., CUA President
SESSION   ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Health Policy Forum   X   45 Jeffrey Kaufman, MD, FACS AUA, State and National Update.
Health Policy Forum   X   20 Datta Wagle, MD, FACS - AUA President Healthcare Delivery System in the USA.
Health Policy Forum   X   40 Art Lurvey, M.D., Medical Director J-1, Palmetto GBA Managing Medicare in 2010 and Beyond.
Health Policy Forum   X   50 Susan E. Charkin, MPH, President Healthcents, Inc. Part 1: Relationship of Commercial Contracts to Your Participation in Medicare: Opting Out - Pros and Cons. Part 2: The Financial Impact of ACO’s on Urology Practices.
Health Policy Forum   X   5   Health Policy Survey Results.
Practice Management Course #1 - 7:30 AM - 9:00 AM
Moderator: Amani AbouZamZam, MBA        
SESSION   ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Practice Management Workshop #1 - 9:15 AM - 10:00 AM   X     Mark Painter, Physician Reimbursement Systems Physician Reimbursement Toolkit 2.0: Part 1) Reimbursement 2010 Coding and Practice Strategies - Positioning for Turmoil; Part 2) EMR meaningful use - How do I get my ARRA money
Practice Management Course #2 - 9:15 AM - 10:00 AM
Moderator: Amani AbouZamZam, MBA        
SESSION   ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Practice Management Workshop #2   X     Alan Weinberg, M.D. Strategies of Office Overhead Reduction:  Controlling Cost and Maximizing Profit in the 2010 Medical Environment
Practice Management Course #2 - 10:15 AM - 11:00 AM
Moderator: Amani AbouZamZam, MBA        
SESSION   ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Practice Management Workshop #3   X     Quentin Clemens, M.D. Quality Reporting – Why Should I Bother?
Sunday, October 24, 2010        
Resident's Program "Survival After Residency" -11:30 AM - 1:00 PM
Objectives: 1) Reviewing How to decide on the right job, assessing joining a large or small practice, or partnership. 2) Discussing insurance, reimbursements and coding procedures. 3) How to get started in today's economic landscape.
Program Planner: Jonathan Perley, M.D.        
SESSION   ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Resident's Program   X     Jonathan Perley, M.D. "Survival After Residency - Learning the Business Side of Your Practice"
Sunday, October 24, 2010        
Poster Session III: Kidney & Laparoscopy- 3:30 PM - 5:30 PM
Objectives: 1) Compare treatment options for small renal masses. 2) Access different techniques of robotic/laparoscopic partial nephrectomy. 3) Characterize renal lesions in patients with HIV and hepatitis 
Program Planner: Paul Andrews, M.D.        
Moderators: Paul Kozlowski, M.D.Premal Desai, M.D.      
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Poster Session III - Kidney & Laparoscopy 93 X No ppt received 2 Henry P. Gottsch, M.D., MS Delayed Complication Rate for Conservative Management of Grade 3 Renal Lacerations.
Poster Session III - Kidney & Laparoscopy 94 X   2 Jeffrey M. Woldrich, M.D. Trends in Surgical Management of Renal Lesions: A Comparison of Probe Ablation, Partial and Radical Nephrectomy in the Nationwide Inpatient Sample.
Poster Session III - Kidney & Laparoscopy 95 X   2 Ronald B. Moore, M.D., PhD Tyrosine Kinase and mTOR Inhibitors Reduce RCC Migration in Vitro and Tumor Growth, Invasion and Metastasis in an Orthotopic Mouse Model.
Poster Session III - Kidney & Laparoscopy 96 X No ppt received 2 George L. Martin, M.D. Out with the Old, In with the New: Laparoscopic Bilateral Native Nephrectomies with Simultaneous Renal Transplantation.
Poster Session III - Kidney & Laparoscopy 97 X No ppt received 2 Robert Torrey, M.D. Robotic Assisted Laparoscopic Partial Nephrcetomy in Lesions Larger Than 4cm.
Poster Session III - Kidney & Laparoscopy 98 X   2 Andrew J. Hung, M.D. “TRIFECTA” in Laparoscopic Partial Nephrectomy.
Poster Session III - Kidney & Laparoscopy 99 X   2 George L. Martin, M.D. Comparison of Total, Selective, and Non-arterial Clamping Techniques during Laparoscopic and Robot Assisted Partial Nephrectomy.
Poster Session III - Kidney & Laparoscopy 100 X No ppt received 2 Dan Lewinshtein, M.D. Laparoscopic Partial Nephrectomy: The Virginia Mason Experience.
Poster Session III - Kidney & Laparoscopy 101 X   2 Jacqueline D. Villalta, M.D. Selective Arterial Embolization for Angiomyolipoma Using Microparticles: Concern for Respiratory Complications.
Poster Session III - Kidney & Laparoscopy 102 X   2 Monish Aron, M.D. Combined LESS and Needlescopic (CLAN) Partial Nephrectomy for Renal Tumor.
Poster Session III - Kidney & Laparoscopy 103 X   2 Andre K. Berger, M.D. Laparoscopic Radical Nephroureterectomy for Upper Tract TCC: Oncologic Outcomes at 7 Years.
Poster Session III - Kidney & Laparoscopy 104 X   2 Sean Stroup, M.D. Laparoscopic Partial Nephrectomy vs. Renal Cryoablation: A Multicenter Comparison of Intermediate Oncologic Outcomes
Poster Session III - Kidney & Laparoscopy 105 X   2 Sean P. Stroup, M.D. Recurrence Rates Following Percutaneous and Laparoscopic Renal Cryoablation of Small Renal Masses: Does the approach make a difference?
Poster Session III - Kidney & Laparoscopy 106 X 3rd Place MBW Essay 2 Christopher Tenggardjaja, M.D. Total Radiation Exposure During an Acute Stone Event in Patients With and Without Private Insurance.
Poster Session III - Kidney & Laparoscopy 107 X 3rd Place JFM Essay.  2 Jared M. Whitson, M.D. Population Based Analysis of Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus.
Poster Session III - Kidney & Laparoscopy 108 X   2 Jeffrey M. Woldrich, M.D. Variations in Incidence of and Risk Factors for Development Anemia and Erythropoiesis Stimulating Agent Utilization after Radical or Partial Nephrectomy.
Poster Session III - Kidney & Laparoscopy 109 X   2 Jared M. Whitson, M.D. Factors Associated with Surgery in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus.
Poster Session III - Kidney & Laparoscopy 110 X   2 Rafael Nuñez-Nateras M.D. The Surgical Approach for Partial Nephrectomy and the Impact on Renal Function.
Poster Session III - Kidney & Laparoscopy 111 X No ppt received 2 Ryan J. Bowman, M.D. Hand-assisted Laparoscopic Donor Nephrectomy Using Only 5mm Ports.
Poster Session III - Kidney & Laparoscopy 112 X   2 Mark D. Tyson M.D. Risk Factors for Ureteral Stricture Formation in Laparoscopically Procured Living Donor Kidney Transplantation.
Poster Session III - Kidney & Laparoscopy 113 X   2 Kiara K. Hennessey, M.D. Long Term Analysis of Post-Renal Transplant Donor Outcomes: Donor Recovery.
Poster Session III - Kidney & Laparoscopy 114 X   2 Jeffrey M. Woldrich, M.D. Estimating the Actual Incidence of Allograft Torsion in the U.S. Kidney Transplant Population Over a 10 Year Period.
Poster Session III - Kidney & Laparoscopy 115 X   2 Jeffrey M. Woldrich, M.D. Characterization of Renal Neoplasms In Patients With And Without HIV Infection.
Poster Session III - Kidney & Laparoscopy 116 X   2 Jeffrey M. Woldrich, M.D. Characterization of Renal Neoplasms in Patients With and Without Hepatitis C Infection.
Poster Session III - Kidney & Laparoscopy 117 X   2 Jennifer N. Wu, M.D. Validation of the 2009 UICC/AJCC TMN Staging System for Renal Cell Carcinoma with Venous Extension “The International Renal Cell Carcinoma-Venous Thrombus Consortium”.
Poster Session III - Kidney & Laparoscopy 118 X   2 Monish Aron, M.D. Impact of Open Versus Laparoscopic Partial Nephrectomy on Flank Muscle Thickness, Flank Bulge and Clinical Symptoms.
Poster Session III - Kidney & Laparoscopy 119 X No ppt received 2 James Porter, M.D. Single Incision Laparoscopic Surgery: Initial Experience.
Poster Session III - Kidney & Laparoscopy 120 X No ppt received 2 Ryan Kopp, M.D. Prospective Comparison of Laparoendoscopic Single Site Surgery and Multiport Laparoscopy for Upper Urinary Tract Surgery.
Sunday, October 24, 2010        
Poster Session IV: Prostate 2 - Unmoderated - All Day Viewing
Objectives: 1) Characterize predictors of recurrence after radical prostatectomy. 2) Access the efficacy of laser technologies for the treatment of BPH. 3) Understand the learning curve for robotic prostatectomy.
Program Planner: Paul Andrews, M.D.        
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Poster Session IV - Prostate 2 121 X     Diana Londoño, M.D. Salvage Cryotherapy of the Prostate: A Prospective Study of Quality of Life Indicators.
Poster Session IV - Prostate 2 122 X     Polina Reyblat, M.D. Management of Intractable Bladder Neck Contracture and Urinary Incontinence: Long Term of Evaluation.
Poster Session IV - Prostate 2 123 X     Nazish Durrani, M.D. Pre-Operative Parameters of PSA Failure.
Poster Session IV - Prostate 2 124 X     Nazish Durrani, M.D. Functional Outcomes of Open Laparoscopic Robotic Prostatectomies.
Poster Session IV - Prostate 2 125 X     Howard Jung, M.D. The Learning Curve of Laparoscopic Vs. Robotic Surgeons During the Implementation of a Robotic Prostatectomy Program.
Poster Session IV - Prostate 2 126 X     Bertram A. Lewis, Jr., M.D., Ph.D., FACS PCA-3 Correlates Better Than PSA to Positive Prostate Biopsies as Studied in a Community Office.
Poster Session IV - Prostate 2 127 X     Alex Kavanagh, M.D. Impedance Tomography Sensor for Cavernous Nerve Mapping.
Poster Session IV - Prostate 2 128 X     J. Kellogg Parsons, M.D. Hospitalization Trends in Benign Prostatic Hyperplasia.
Poster Session IV - Prostate 2 129 X     Osamu Ukimura, M.D. Elastic Registration of 3D Prostate Biopsy Trajectory by MR/TRUS Fusion: Pilot Phatom Study.
Poster Session IV - Prostate 2 130 X     William Tu, M.D. Ph.D. Racial Disparities in Medical and Surgical Treatment of Benign Prostatic Hyperplasia.
Poster Session IV - Prostate 2 131 X     Chong "Jay" Choe, M.D. The Use of Enseal in Nerve Sparing Rbotic Prostatectomy: No Energy or Smart Energy?
Poster Session IV - Prostate 2 132 X     David Aaronson, M.D. Regional Availability of Proton Beam Therapy and Variation in Treatment for Men with Low Risk Prostate Cancer in California.
Poster Session IV - Prostate 2 133 X     Jonathan N. Warner, M.D. Functional Outcomes Following HOLEP on Patients with Previous Surgical Treatment for BPH.
Poster Session IV - Prostate 2 134 X     Jonathan N. Warner, M.D. An Evaluation of Outcomes of Patients with Pre-Operative Urinary Retention After HOLEP.
Poster Session IV - Prostate 2 135 X     Scott M. Cheney, M.D. Maximization of Scope Flow Rates for Trans-Urethral Surgery.
Poster Session IV - Prostate 2 136 X     Daniel W. Lin, M.D. Toremifene Demonstrates Reduction In Fracture Risk In Men Less Than 80 Years Of Age On Androgen Deprivation Therapy.
Poster Session IV - Prostate 2 137 X     Geoffrey Gotto, M.D. A Single Surgeon’s Learning Curve Following Adoption Of Robotic-Assisted Laparoscopic Prostatectomy.
Poster Session IV - Prostate 2 138 X     Heather Willis, M.D. Comparisons of Patient Outcomes for Robotic and Open Prostatectomies.
Poster Session IV - Prostate 2 139 X     Rafael Nuñez-Nateras M.D. Morcellation Efficiency: A Comparison Study Using Prostate Surrogate Tissue.
Poster Session IV - Prostate 2 140 X     Jason Y. Lee, M.D. Robotic Surgery Training & Credentialing in Urology - Looking Forward.
Poster Session IV - Prostate 2 141 X     Mitchell R. Humphreys, M.D. Incidental Prostate Cancer Revisited: Early Outcomes of T1a and T1b After Holmium Laser Enucleation of the Prostate (HoLEP).
Poster Session IV - Prostate 2 142 X     Shunichi Namiki, M.D. Ethnic Variation in Quality of Life for Localized Prostate Cancer: A Cross Cultural Study Among Japanese, Caucasian and Japanese-American Men.
Poster Session IV - Prostate 2 143 X     Mohamed H. Etafy M.D Rapid Versus Gradual Decompression of the Bladder in Patients with Acute Urinary Retention Secondary to Benign Prostatic Hyperplasia.
Poster Session IV - Prostate 2 144 X     Dani H. Farhat, B.A. Robotic Barbed, Unidirectional Suture Efficiency And Safety In a Modeled, Vesicourethral Anastomosis.
Poster Session IV - Prostate 2 145 X     Dan Lewinshtein, M.D. Should Voiding Symptoms Based on AUA Symptom Score Be Used to Order a PSA Test?
Poster Session IV - Prostate 2 146 X     Jeffrey M. Woldrich, M.D. Comparison of Immediate Outcomes in Veterans Administration Patients Undergoing Robot Assisted Laparoscopic Prostatectomy (RALP) by Residents Supervised by High and Low Volume Surgeons.
Poster Session IV - Prostate 2 147 X     Joseph C. Presti, Jr., M.D. Alcohol Ingestion and Adverse Features at Radical Prostatectomy – Should We Drink To That?
Poster Session IV - Prostate 2 148 X     Torrence M. Wilson, M.D. Clinical Evaluation During Permanent Prostate Brachytherapy of Two Probes used for Trans-Urethral Ultrasound (TUUS).
Poster Session IV - Prostate 2 149 X     Joey Roy, M.D.,C.M. Pathologic Outcomes Of Candidates For Active Surveillance Treated With Radical Prostatectomy: Results From The University Of Alberta Radical Prostatectomy Database.
Poster Session IV - Prostate 2 150 X     Leah Nakamura, M.D. Comparing Approaches of an Inguinal Hernia Repair During a Simultaneous Robot Assisted Radical Prostatectomy.
Poster Session IV - Prostate 2 151 X     Franklin D. Gaylis, M.D. Technical Modifications to Suprapubic Prostatectomy.
Poster Session IV - Prostate 2 152 X     Caroline Colangelo, M.D. Ciprofloxacin Use in Patients Who Develop Fluoroquinolone Resistant Bacterial Infections After Transrectal Ultrasound Guided Needle Biopsy of the Prostate.
Poster Session IV - Prostate 2 153 X     Steven A. Kaplan, M.D. Is Silodosin-Mediated Improvement in Symptoms of Benign Prostatic Hyperplasia (BPH) Affected by Prostate Volume?
Poster Session IV - Prostate 2 154 X     John M. Corman, M.D. Survival Results of the IMPACT Trial of Sipuleucel-T for Advanced Prostate Cancer.
Poster Session IV - Prostate 2 155 X     John R. Day, Ph.D. Validation of the PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in the Placebo Arm of the Dutasteride REDUCE Trial.
Poster Session IV - Prostate 2 156 X     Michael A. Carducci, M.D. A Phase 3 Randomized Trial of Denosumab Versus Zoledronic Acid in Patients With Bone Metastases From Castration-Resistant Prostate Cancer.
Poster Session IV - Prostate 2 157 X     John R. Day, Ph.D. PCA3 Predicts Prostate Biopsy Outcome in Men Receiving Dutasteride: Results from the REDUCE Trial.
Poster Session IV - Prostate 2 158 X     Adam C. Reese, M.D. Non-Steroidal Anti-Inflammatory Drugs Do Not Suppress PSA Nor Result in Delayed Diagnosis of Prostate Cancer.
Poster Session IV - Prostate 2 159 X     Jennifer N. Wu, M.D. Current Patient Perception of Laparoscopic and Robotic Technologies in Surgery.
Poster Session IV - Prostate 2 160 X     Dan Lewinshtein, M.D. Can TMPRSS-ERG Fusion Status Help Predict Treatment Outcome In Urology?
Poster Session IV - Prostate 2 161 X     Jay M. Young, M.D. The Safety and Efficacy Profile of Leuprolide Acetate 6 Month Depot in Men with Prostate Cancer.
Poster Session IV - Prostate 2 162 X     Brian E. Mayson, M.D. A Rare But Serious Complication of KTP Photoselective Vaporization of the Prostate: Prostatic Capsular Perforation with Bilateral Thigh Urinomas and Osteitis Pubis.
Poster Session IV - Prostate 2 163 X     John C. Campbell, BSc Efficacy and Safety of a Once-Yearly Histrelin Acetate Implant (VANTAS®) Compared with 3-Month Goserelin Acetate Implants in Patients with Metastatic Prostate Cancer.
Poster Session IV - Prostate 2 164 X     Xiaoming Li, M.D., Ph.D. Pegylated Human Recombinant Hyaluronidase PH20 (PEGPH20) Combined with Finasteride Inhibits Prostatic Hyperplasia in the Rat Testosterone Enanthate Prostatic Hyperplasia Model.
Poster Session IV - Prostate 2 165 X     Curtis Dunshee, M.D. Zibotentan For The Treatment Of Castration-Resistant Prostate Cancer - An Overview Of The Phase III ENTHUSE Program With A Focus On The Ongoing Trial In Non-Metastatic Patients.
Poster Session IV - Prostate 2 166 X     Peter N. Schlegel, M.D., FACS Evaluation of the Pharmacokinetics and Pharmacodynamics of a Once-Yearly Histerlin Acetate Implant (VANTAS®) in Patients with Prostate Cancer and Renal or Hepatic Impairment.
Poster Session IV - Prostate 2 167 X     Andrew Hung, M.D. Obturator Neuropraxia After Robotic Radical Prostatectomy and Pelvic Lymphadenectomy: An Unusual Cause.
Sunday, October 24, 2010        
Poster Session V: Pediatrics & Sexual Medicine - All Day Viewing
Objectives: 1) Discuss the treatment of pediatric urologic diseases. 2) Diagnosis disease process associated with pelvic sexual medicine. 3) Understand the epidemiology of hypospadias.
Program Planner: Paul Andrews, M.D.        
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Poster V Pediatrics & Sexual Medicine 168 X     Sean Q Kern, M.D. A Case Report: Bilateral Fibrous Pseudotumors in a Pediatric Patient.
Poster V Pediatrics & Sexual Medicine 169 X     Elizabeth M. Mobley, M.D. Epidemiologic Characteristics of Hypospadias in Utah, 1999-2007.
Poster V Pediatrics & Sexual Medicine 170 X     Ryan W. Speir, M.D. Persistent Mullerian Duct Syndrome, A Case Report.
Poster V Pediatrics & Sexual Medicine 171 X     Gregory E. Tasian, M.D. Imaging Utilization and Cryptorchidism: Determinants of Practice Patterns.
Poster V Pediatrics & Sexual Medicine 172 X     Heather L. Willis, M.D. Parameatal Urethral Cysts in Pre-Pubertal Males.
Poster V Pediatrics & Sexual Medicine 173 X     Antoine E. Khoury, M.D. Development of Macroplastique Bolus Calcification Detected During Long Term Follow up After Injection for Vesico- Ureteral Reflux.
Poster V Pediatrics & Sexual Medicine 174 X     Chasta-Dawne L. Bacsu, M.D. Are Urinary Tract Infections and Hydronephrosis Predictive of Decreased Renal Graft Function?
Poster V Pediatrics & Sexual Medicine 175 X     J. Scott Gabrielsen B.S.* Stone Composition in Pediatric Patients.
Poster V Pediatrics & Sexual Medicine 176 X     Gregory E. Tasian, M.D. Boys with Proximal Hypospadias are at Increased Risk for Developing Acquired Cryptorchidism.
Poster V Pediatrics & Sexual Medicine 177 X     Siam Oottamasathien M.D. Abrogation of LL-37 Mediated Bladder Inflammation and the Role of the Receptor for Advanced Glycation End-Products Pathway.
Poster V Pediatrics & Sexual Medicine 178 X     Jeffrey M Woldrich, M.D Urologic Findings on Computed Tomography of the Abdomen and Pelvis in a Pediatric Population.
Poster V Pediatrics & Sexual Medicine 179 X     Alex Kavanagh, M.D. Non-functional Upper Pole of a Duplex Collecting System Masquerading as an Antenatal Adrenal Cyst: A Case Study and Review of the Literature.
Poster V Pediatrics & Sexual Medicine 180 X     Mehran Movassaghi, M.D. M.B.A. The Role of TMR in Treatment of Chronic Orchialgia.
Poster V Pediatrics & Sexual Medicine 181 X     Joel M. Kaufman, M.D. Pharmacokinetics and Efficacy of a 1.62% Testosterone Gel for the Treatment of Hypogonadal Men: Secondary Efficacy Results From a Phase III Study.
Poster V Pediatrics & Sexual Medicine 182 X     Irwin Goldstein, M.D. Varied Histories of Blunt Perineal Trauma in Young Men with Erectile Dysfunction who Undergo Penile Revascularization Surgery.
Poster V Pediatrics & Sexual Medicine 183 X     Irwin Goldstein, M.D. Surgical Treatment of Women with Sexual Pain Disorders of the Vulva and Vestibule.
Poster V Pediatrics & Sexual Medicine 184 X     Megan M Melnyk, M.D. Teaching of the Male Urogenital Exam in Medical School: Are Our Students Appropriately Prepared for Practice?
Poster V Pediatrics & Sexual Medicine 185 X     James Dow, M.D. A Modification of Current Application and Activation Technique Improves Overall Response to MUSE Therapy.
Poster V Pediatrics & Sexual Medicine 186 X     Irwin Goldstein, M.D. The Medtronic Zotarolimus-Eluting Peripheral Stent System for the Treatment of Erectile Dysfunction in Males with Sub-Optimal Response to Pde5 Inhibitors – Rationale.
Poster V Pediatrics & Sexual Medicine 187 X     Irwin Goldstein, M.D. Optimizing Patient Care Using Subcutaneous Testosterone Pellet Implant (Testopel®) Therapy for Symptomatic Men and Women with Hypogonadism (Testosterone Deficiency Syndrome).
Poster V Pediatrics & Sexual Medicine 188 X     Steven K. Wilson, MD, FACS, FRCS The Search for the Ideal Antibiotic Dip for the Coloplast Titan Prosthesis.
Poster V Pediatrics & Sexual Medicine 189 X     Guillermo Patino, D.O. Obstructive Azoospermia Presenting With Congenital Absence Of The Seminal Vesicles And Cystic Fibrosis Carrier State.
Poster V Pediatrics & Sexual Medicine 190 X     Su-Yeon Jang, M.D. Our Experiences For Simultaneous Penile Curvature Correction And Penile Enhancement Surgery.
Poster V Pediatrics & Sexual Medicine 191 X     Su-Yeon Jang, M.D. Evaluation of Sexual Functions and Patterns of Patients who Underwent Penile Augmentation Surgery.
Poster V Pediatrics & Sexual Medicine 192 X     Mehran Movassaghi, M.D. M.B.A. Local Anesthesia Irrigation Technique Reduces Post-operative Pain Following Vasectomy Reversal.
Poster V Pediatrics & Sexual Medicine 193 X     Glen Yang, M.D. Urology Resident Publication Output and Its Relationship to Future Academic Achievement.
Poster V Pediatrics & Sexual Medicine 194 X     Maurice M. Garcia, M.D. You Don’t Always Get What You Want: Fluid, Drainage Tube Position, and Dependent Loops Impair Chest Tube Function.
Poster V Pediatrics & Sexual Medicine 195 X     John P. Brusky, M.D. What the Electronic Medical Record (EMR) Can and Can't Do For Your Urology Practice.
Poster V Pediatrics & Sexual Medicine 196 X     Kathleen A. O’Connor, PhD* Man Up: Qualitative Findings from the Health Initiatives for Men (HIM) Study.
Poster V Pediatrics & Sexual Medicine 197 X     Jen Jane Liu, M.D. Cost Savings in Urology Operating Rooms By Reducing Waste of Disposable Items.
Poster V Pediatrics & Sexual Medicine 198 X     Cory Bates, M.D. Are We Contributing to the Prescription Drug Abuse Problem?  A Look at Post-Operative Pain Medication Prescribed Compared to that Actually Consumed in Urologic Practice.
Poster V Pediatrics & Sexual Medicine 199 X     Kiara K Hennessey, M.D. Duplicate Publications: A Survey of Redundancy in the Urological Literature.
Poster V Pediatrics & Sexual Medicine 200 X     CPT. Patrick S. McDonough, M.D. Initial Validation of the ProMIS Surgical Simulator as an Objective Measure of Robotic Task Performance.
Poster V Pediatrics & Sexual Medicine 201 X     Anthony H. Horan, M.D. An Error in the Management of Adenocarcinoma of the Urachus 'Saved' by Staged Bilateral Cutaneous Ureterostomies.
Poster V Pediatrics & Sexual Medicine 202 X     Daniel B. Morilla, M.D. Synchronous Metastasis of RCC to the Ipsilateral Ureter: A Case Report and Review of the Literature.
Poster V Pediatrics & Sexual Medicine 203 X     Daniel B. Morilla, M.D. Inflammatory Myofibroblastic Tumor of the Bladder: A Case Report and Review of the Literature.
Poster V Pediatrics & Sexual Medicine 204 X     John P. Brusky, M.D. Development of an Unusual Testicular Tumor After Trauma to the Testicle.
Poster V Pediatrics & Sexual Medicine 205 X     Anthony H. Horan, M.D. The Cure of 'Bother' Explains the Exponential Growth of Microwave Utilization.
Poster V Pediatrics & Sexual Medicine 206 X     Bertram A. Lewis, Jr., M.D., Ph.D., F.A.C.S How One Metastatic Cancer in the Hand is Worth More Than Two Primary Cancers in the Bush and What This Has To Do with Voltaire's Candide.
Poster V Pediatrics & Sexual Medicine 207 X     Jeremy M. Blumberg, M.D. Holmium Laser Cystolitholapaxy Thorugh a Standard Resectoscope Sheath Likely Improves Both Visualization and Stone Fragment Evacuation.
Poster V Pediatrics & Sexual Medicine 208 X     Charles Metcalfe, M.D. Ballooning the IVC for a Bloodless Thrombectomy.
Poster V Pediatrics & Sexual Medicine 209 X     Chasta-Dawne L. Bacsu, M.D. An Unusual Case of Priapism in an Infant.
Poster V Pediatrics & Sexual Medicine 210 X     Christopher F. Tenggardjaja, M.D. Vastly Differential Torsion.
Poster V Pediatrics & Sexual Medicine 211 X     Michael A. Liss, M.D. Holmium Laser Fulguration of Superficial Urothelial Carcinoma of the Urethra.
Poster V Pediatrics & Sexual Medicine 212 X     Gladys Y. Ng, M,D., MPH Novel Use of Cystoscopy in A Robotic-Assisted Laparoscopic Bladder Diverticulectomy.
Poster V Pediatrics & Sexual Medicine 213 X     Jennifer Wu, M.D. A Report of the Surgical Management of a Renal Mass and Hepatic Caval Thrombus in a Horseshoe Kidney.
Poster V Pediatrics & Sexual Medicine 214 X     Jason M. Durbin, D.O. Effect of Perioperative Benzodiazipine on Vasectomy Pain and Anxiety During a Routine in Office Procedure.
Poster V Pediatrics & Sexual Medicine 215 X     Jeffrey M. Woldrich, M.D. Penile Kaposi's Sarcoma in the State of California.
Sunday, October 24, 2010        
Poster Session VI: Kidney, Calculi, Bladder - Unmoderated - All Day Viewing
Objectives: 1) Discuss various techniques of laparoscopic donor nephrectomy. 2) Better understand the management of nephrolithasis. 3) Access outcomes for robotic /laparoscopic surgery of the upper tract.
Program Planner: Paul Andrews, M.D.        
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Poster VI Kidney, Calculi, Bladder 216 X     Jason P. Smith, M.D. The Use of a Biologic Hemostatic Agent in Laparoscopic Partial Nephrectomy.
Poster VI Kidney, Calculi, Bladder 217 X     Alex Kavanagh, M.D. Early Experience with Robot Assisted Laparoscopic Donor Nephrectomy.  
Poster VI Kidney, Calculi, Bladder 218 X     Michael W. McDonald, M.D. Robotic Assisted Laparoscopic Partial Nephrectomy: The First 10 Cases in a Community Hospital Setting.
Poster VI Kidney, Calculi, Bladder 219 X     Andre K. Berger, M.D. Evolution of Laparoscopic Partial Nephrectomy.
Poster VI Kidney, Calculi, Bladder 220 X     Catherine Harris, M.D. Oncologic Outcomes of Partial Nephrectomy versus Ablation of Small Renal Masses in a Population Based Cohort.
Poster VI Kidney, Calculi, Bladder 221 X     Faiz S Nasser, M.D. Reviewing Radiographic Images With Patients: A Prospective Randomized Controlled Trial On Patient Satisfaction, Understanding, And Preferences.
Poster VI Kidney, Calculi, Bladder 222 X     Phillip Mucksavage, M.D. Preoperative Warm Up Excercises Improve Laparoscopic Operative Times in an Experienced Laparoscopic Surgeon.
Poster VI Kidney, Calculi, Bladder 223 X     Natalya Lopushnyan M.D. Analysis of Renal Injury After Skiing and Snowboarding Accidents.
Poster VI Kidney, Calculi, Bladder 224 X     Mitchell R. Humphreys, M.D. A New Dissolvable Mechanical Knot Making NOTES a Reality in the Urinary System.
Poster VI Kidney, Calculi, Bladder 225 X     Jonathan N. Warner, M.D. Complications After Stent Removal in Patients Treated with Ureteroscopy for Ureteral Stones.
Poster VI Kidney, Calculi, Bladder 226 X     Adam C. Reese, M.D. Association of Nephrolithiasis with Renal Disease in Women.
Poster VI Kidney, Calculi, Bladder 227 X     Scott Willard, B.S. Internet Search Trend Metrics Can Provide Real Time Data on Kidney Stone Disease in the United States.
Poster VI Kidney, Calculi, Bladder 228 X     Nathan Hoag, M.D. Drainage Characteristics of a Novel 3 Fr Stent Utilizing a Film Anchoring Device.
Poster VI Kidney, Calculi, Bladder 229 X     Eric S. Reid, M.D. Metabolic Risk Factors in Patients with Intraparenchymal Calcifications.
Poster VI Kidney, Calculi, Bladder 230 X     Tin C. Ngo, M.D. Tracking Intra-operative Fluoroscopy Time Reduces Radiation Exposure During Ureteroscopy.
Poster VI Kidney, Calculi, Bladder 231 X     Jennifer Sung, M.D. Metabolic Syndrome and Urolithiasis.
Poster VI Kidney, Calculi, Bladder 232 X     Lipi McCauley, M.D. Factors Influencing Fluid Intake Behavior Among Kidney Stone Patients.
Poster VI Kidney, Calculi, Bladder 233 X     Christopher F Tenggardjaja, M.D. Stone Weighted Appearance on Axial-slice Technique (SWAT) - a More Accurate Method for Evaluating Ureteral Stones in the Craniocaudal Dimension.
Poster VI Kidney, Calculi, Bladder 234 X     Gautum Agarwal, M.D. Insurance Status and Emergency Department Utilization in Patients with Acute Stone Episodes.
Poster VI Kidney, Calculi, Bladder 235 X     Matthew D. Dunn, M.D. Early experience With A One Step Combination Dilating Nephrostomy Balloon And Expandable Sheath For Percutaneous Renal Surgery.
Poster VI Kidney, Calculi, Bladder 236 X     Gautum Agarwal, M.D. Effect of Kidney Rest on Postoperative Creatinine Kinase Levels in Laparoscopic Donor Nephrectomy.
Poster VI Kidney, Calculi, Bladder 237 X     Christopher F. Tenggardjaja, M.D. Patients Who Lack Private Insurance Are Exposed to More Radiation and Incur Greater Imaging Costs During an Acute Stone Episode.
Poster VI Kidney, Calculi, Bladder 238 X     Jeremy Blumberg, M.D. Transumbilical Dismembered Pyeloplasty.
Poster VI Kidney, Calculi, Bladder 239 X     Andre Berger, M.D. Reconstructive Laparoendoscopic Single-Site (LESS) Surgery for the Upper Tract.
Poster VI Kidney, Calculi, Bladder 240 X     Ryan J. Bowman, M.D. Fluoroless Ureteroscopy – Is It Possible?
Poster VI Kidney, Calculi, Bladder 241 X     Mohamed H. Etafy, M.D. Robot Assisted Laparoscopic Dismembered Pyeloplasty for Ureteropelvic Junction Obstruction: The University of California, Irvine Experience.
Poster VI Kidney, Calculi, Bladder 242 X     Gwen M. Grimsby, M.D. Outcomes and Patient Satisfication After Robotic Sacrocolpopexy.
Poster VI Kidney, Calculi, Bladder 243       Ali Zhumkhawala, M.D. Why Patients Stop Taking Anticholinergic Medications For Overactive Bladder: Creation and Results of a Validated Questionnaire.
Poster VI Kidney, Calculi, Bladder 244 X     Viet Tran, M.D. Assessment of Vitamin B12 Level After Augmentation Ileocystoplasty in Patients with Neurogenic Bladder Due to Spinal Cord Injury.
Poster VI Kidney, Calculi, Bladder 245 X     Sepehr Nowfar, M.D. The Relationship of Obesity, Gender, and Nephrolithiasis in the United States: a Review of the Nationwide Inpatient Sample Database.
Poster VI Kidney, Calculi, Bladder 246 X     Robert Laciak, M.D. Unusual Presentation of Antibiotic Allergy Following Placement of Antibiotic Impregnated Inflatable Penile Prosthesis.
Poster VI Kidney, Calculi, Bladder 247 X     Simon Y. Kimm, M.D. Improved Satisfaction And Quality Of Life After Ileocecocystoplasty And Continent Urinary Diversion In Patients With Spinal Cord Injury.
Poster VI Kidney, Calculi, Bladder 248 X     Pejvak Sassani, M.D. Pre-operative Predictors of Success and of Complications with ACT® implantation for Stress Urinary Incontinence.
Poster VI Kidney, Calculi, Bladder 249 X     Gary G. Kay*, Ph.D. Effects of Topical and Oral Oxybutynin on Cognition in Older Adults—A Double-Blind, Placebo-Controlled Study Employing Sensitive Cognitive and Psychomotor Testing.
Poster VI Kidney, Calculi, Bladder 250 X     Polina Reyblat, M.D. Urologic Management of Adult Patients with Neurogenic Bladder and Myelomeningocele.
Poster VI Kidney, Calculi, Bladder 251 X     Craig V. Comiter, M.D A Prospective Analysis of Video-Urodynamic Data to Measure Urethral Mobility in Men with Post-Prostatectomy Stress Incontinence.
Poster VI Kidney, Calculi, Bladder 252 X     Tin C. Ngo, M.D. Sacral Nerve Stimulator Revision/Replacement in Children Due to Somatic Growth.
Poster VI Kidney, Calculi, Bladder 253 X     Peter Black, M.D., FRCSC Penile Carcinoma: Lessons Learned from Vulvar Carcinoma.
Poster VI Kidney, Calculi, Bladder 254 X     Maurice M. Garcia, M.D. Do Urologists Understand How Foley Catheters Actually Work?: Results of a Nationwide Survey.
Poster VI Kidney, Calculi, Bladder 255 X     David S. Aaronson, M.D. National Incidence and Impact of Non-Infectious Urethral Catheter Related Complications.
Poster VI Kidney, Calculi, Bladder 256 X     Jeffrey Woldrich, M.D. Parathyroid Hormone Related Protein as a Biomarker for Squamous Differentiation of Urothelial Cells of the Bladder.
Poster VI Kidney, Calculi, Bladder 257 X     Andre Berger M.D. Extended Pelvic Lymph Node Dissection During Robotic and Laparoscopic Radical Cystectomy.
Poster VI Kidney, Calculi, Bladder 258 X     Gwen M. Grimsby, M.D. Case Report of Signet Ring Adenocarcinoma in a Female Urethral Diverticulum.
Poster VI Kidney, Calculi, Bladder 259 X     Gene O. Huang, M.D. Classic Kaposi’s Sarcoma Manifesting as a Urethral Lesion.
Poster VI Kidney, Calculi, Bladder 260 X     Donald L. Lamm, M.D. Reduction of Pelvic Recurrence at Cystectomy.
Poster VI Kidney, Calculi, Bladder 261 X     Chris M. Whelan, M.D. Robotic Assisted Laparoscopic Total Pelvic Exenteration: Early Experience.
Poster VI Kidney, Calculi, Bladder 262 X     Kevin G Chan, M.D. Functional Outcomes and Complications in Patients Undergoing Robotic Assisted Radical Cystectomy and Indiana Pouch Urianry Diversion.
Poster VI Kidney, Calculi, Bladder 263 X     Mitchell R. Humphreys, M.D. Making NOTES a Reality in the Urinary System: A New Dissolvable Alloy Knot System.
Poster VI Kidney, Calculi, Bladder 264 X     Michael A. Liss, M.D. Pilot Study of OAB inhibitor Solifenacin for improvement of Time to Urinary Continence after Hypothermic Robotic-Assisted Radical Prostatectomy.
Poster VI Kidney, Calculi, Bladder 265 X     Robert Torrey, M.D. Robotic-assisted Laparoscopic Partial Nephrectomy: Single Institution Experience.
Monday, October 25, 2010        
Postgraduate Review & Examination Preparation Courses - Course Director: Mitchell Sokoloff, MD, University of Arizona, Tucson, AZ
PREP-C #1: Female Urology - 7:45 AM - 9:45 AM      
Objectives: 1)  Describe the relevant neural and pharmacological events of urinary storage and emptying. 2)  Compare and describe the essential parameters urodynamic patterns encountered in evaluating incontinence. 3)  Assess the modern treatment options for stress incontinence, their success rates, and most common complications. 4)  Discuss the modern treatment options for urge incontinence, their success rates, and most common complications.  
Course Planner: Christian Twiss, M.D. / Faculty: Ja-Hong Kim, M.D.
SESSION TIME ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
PREP-C #1: Female Urology 7:45 AM X   30 Christian Twiss, M.D. Neural Control of Micturition.
PREP-C #1: Female Urology 8:15 AM X No ppt received 30 Ja-Hong Kim, M.D. Evaluation / Urodynamics
PREP-C #1: Female Urology 8:45 AM X No ppt received 30 Ja-Hong Kim, M.D. Stress Incontinence Management
PREP-C #1: Female Urology 9:15 AM X   30 Christian Twiss, M.D. Urge Incontinence Management
PREP-C #2 Testis & Penile Cancers - 7:45 AM - 9:45 AM
Objectives: 1)  Describe the histologic subtypes of benign and malignant tumors of the testis and penis. 2)  Discuss the surgical and medical management of cancers of the testis and penis. 3)  Appreciate the role of multimodality therapies.
Course Planner: Hyung Kim, M.D. / Faculty: Maxwell Meng, M.D.
SESSION TIME ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
PREP-C #2 Testis & Penile Cancers 7:45 AM X   30 Hyung Kim, M.D. Testicular Cancer
PREP-C #2 Testis & Penile Cancers 8:45 AM X   30 Maxwell Meng, M.D. Penile Cancers
PREP-C #3 Prostate Cancer - 10:00 AM - 12:00 PM
Objectives: 1)  Describe present issues in cancer prevention and diagnosis. 2)  Improve interpretation and assessment of treatments and actions for localized cancer. 3)  Clarify and discuss use of treatments for metastatic cancer and sequela related to the disease and interactions.
Course Planner: Bruce Dalkin, M.D., FACS / Faculty: Jonathan Wright M.D.
SESSION TIME ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
PREP-C #3 Prostate Cancer 10:00 AM X   30 Bruce Dalkin, M.D., FACS Prostate Cancer Prevention and Diagnosis.
PREP-C #3 Prostate Cancer 10:30 AM X   30 Jonathan Wright, M.D. Treatment of Localized Prostate Cancer.
PREP-C #3 Prostate Cancer 11:00 AM X   30 Bruce Dalkin, M.D., FACS Cancer Control and HRQOL Outcomes in Localized Cancer.
PREP-C #3 Prostate Cancer 11:30 AM X   30 Jonathan Wright, M.D. Management of Metastatic and Hormone Refractory Disease and Complications.
PREP-C #4 Urolithiasis - 10:00 AM - 12:00 PM
Objectives: 1)  Discuss the latest AUA guideline recommendations of nephrolithiasis. 2)  Describe the proper metabolic evaluation and medical management of recurrent stone disease. 3) Evaluate the latest technological developments in managing stone disease.
Course Planner: Matthew Dunn, M.D. / Faculty: Mihir M. Desai, M.D.    
SESSION TIME ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
PREP-C #4 Urolithiasis 10:00 AM X   30 Matthew Dunn, M.D. Review AUA Guidelines, Update on Epidemology
PREP-C #4 Urolithiasis 10:20 AM X   30 Matthew Dunn, M.D. Diagnosis and Proper Work-Up of Stone Disease
PREP-C #4 Urolithiasis 11:00 AM X   30 Mihir M. Desai, M.D. Surgical Management, Latest Technology
PREP-C #4 Urolithiasis 11:30 AM X   30 Mihir M. Desai, M.D. Medical and Dietary Management of Recurrent Stone Disease
PREP-C #5 Radiology - 7:00 AM - 12:00 PM        
Objectives: 1) Discuss appropriate use of imaging modalities for genitourinary diseases. 2) Review current indications, techniques, safety and interpretation of video urodynamics. 3) Discuss the use of new and emerging imaging techniques and their use in the treatment of urologic diseases. 4) Appraise radiation safety issues of computed tomography imaging and in the use of fluoroscopy for endoscopic urologic procedures.
Course Planner: Duane Baldwin, M.D. / Faculty:  TBD      
SESSION TIME ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
PREP-C #5 Radiology 7:00 AM X   5 D. Duane Baldwin, M.D. & David Chamberlin, M.D. Introduction
PREP-C #5 Radiology 7:05 AM X No ppt received 30 Christopher Porter, M.D. State of the Art Ultrasound Imaging for the Urologist
PREP-C #5 Radiology 7:35 AM X No ppt received 20 Damien L. Smith, M.D. Radiation Biology and Radiation Safety
PREP-C #5 Radiology 7:55 AM X No ppt received 30 D. Duane Baldwin, M.D.  State of the Art Imaging for Calculus Disease and Implications for Patient Safety
PREP-C #5 Radiology 8:25 AM X No ppt received 30 David Chamberlin, M.D. State of the Art Imaging In Pediatric Urology and Implications for Patient Safety
PREP-C #5 Radiology 9:05 AM X No ppt received 50 Allie Blackburn, M.D. MRI for the Urologist
PREP-C #5 Radiology 9:55 AM X No ppt received 30 Ja-Hong Kim, M.D. State of the Art Video Urodynamics
PREP-C #5 Radiology 10:35 AM X No ppt received 25 Jason Smith, M.D. New Developments in Abdominal Imaging
PREP-C #5 Radiology 11:00 AM X No ppt received 25 Jason Smith, M.D. Imaging of the Small Renal Mass and Implications of Percutaneous Ablative Therapy
PREP-C #5 Radiology 11:25 AM X No ppt received 30 Herbert Ruckle, M.D. State of the Art Imaging in Urologic Oncology and Implications for Patient Safety
Tuesday, October 26, 2010        
Pelvic Floor Medicine: 7:30 AM - 9:45 AM        
Objectives: 1) Discuss outcomes of slings based on various parameters. 2) Discuss outcomes and potential complications of treatment of male incontinence. 3) Discuss management of spinal cord injury patients with voiding dysfunction.
Program Planner: Kathleen Kobashi, M.D.        
Moderators: Chris Wolter, M.D., Gilberto Brito, M.D.      
Point/Counterpt. Moderator: Kathleen Kobashi, M.D.      
Panel Discuss. Moderator: Craig Comiter, M.D.      
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Pelvic Floor Medicine 266 X State of Art Lecture- No ppt received 25 David Ginsberg, M.D. Neurourology – a Quick Review of All That We Were Supposed To Learn in Residency and Forgot After Boards.
Pelvic Floor Medicine 267 X   5 Jason Kim, M.D. Patient-Reported Outcomes Differ Dependent on Questionnaire.
Pelvic Floor Medicine 268 X   5 Gwen M. Grimsby, M.D. Trends in Success and Complications Based on BMI after Transobturator Male Sling.
Pelvic Floor Medicine 269 X   5 William O Brant, M.D. The Fate of Intentionally Retained Pressure Regulating Balloon in Artificial Urinary Sphincter Placement.
Pelvic Floor Medicine 270 X   5 Andrew Neeb, M.D. High Risk of Infection Following Addition of Tandem Cuff to Artificial Urinary Sphincter.
Pelvic Floor Medicine 271 X   5 Jason Kim, M.D. Worse Surgical Outcomes for Patients Over 70 Undergoing a Retropubic Mid-Urethral Polypropylene Sling.
Pelvic Floor Medicine 272 X   5 Viet Tran, M.D. Long-Term Efficacy of Repeat Incision of Bladder Neck/ External Sphincter in Patients with Spinal Cord Injury Sustained Prior to 1990.
Pelvic Floor Medicine 273 X Point/CounterPoint 30 Larrisa Rodriguez, MD vs. Peter Sand, MD Point Counterpoint: Management of the Apex with Large Anterior Compartment Prolapse.
Pelvic Floor Medicine 274 X Moderator: Craig Comiter, MD 30 Karyn Eilber, MD, Peter Sand, MD, Anthony Stone, MD, Quentin Clemens, MD Panel Discussion: Controversies in Pelvic Floor Medicine.
Tuesday, October 26, 2010        
Sexual Medicine - 10:30 AM - 12:00 PM        
Objectives: 1) Update the surgical management of priapism. 2) Describe the approach to placement of penile prosthesis. 3) Assess the factors that are predictive of vasectomy success.
Program Planner: Tony Khoury, M.D.        
Moderators: Fred Govier, M.D.,  Irwin Goldstein, M.D.      
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Sexual Medicine 275 X   5 Steven K. Wilson, M.D. Synchronous Placement of Inflatable Penile Prosthesis and Male Sling Through a Single Scrotal Incision.
Sexual Medicine 276 X   5 Elizabeth M Mobley, M.D. The Effect Of Inflatable Penile Prosthetics On Penile Length.
Sexual Medicine 277 X   5 Joel M. Kaufman, M.D The Efficacy and Safety of a 1.62% Testosterone Gel for the Treatment of Hypogonadal Men: Efficacy Results From a Phase III Study.
Sexual Medicine 278 X   5 Irwin Goldstein, M.D. Gepirone-Er – A Potential Treatment Option for Men with Sexual and Psychiatric Co-Morbidities.
Sexual Medicine 279 X   5 CPT. Timothy J Tausch, M.D., MC, USA The Use of MRI in Directed Local Exploration of Penile Fracture.
Sexual Medicine 280 X   5 Rei K. Chiou, M.D., Ph.D. Clinical Experience of Priapism Treatment with Penile Cavernoso-Dorsal Vein Shunt Using Saphenous Vein Graft.
Sexual Medicine 281 X   5 Guillermo Patino, D.O. Improvement of Vasectomy Failure Rates Based on Technique.
Sexual Medicine 282 X 2nd Place JFM Essay 5 Maurice M. Garcia, M.D., MAS Light-Induced Dielectrophoresis for the Identification of Viable, Optimal Quality Sperm Within An Unwashed Semen Sample: Feasibility and Safety Studies.
Sexual Medicine 283 X   5 Adrienne Heckler, M.D. Frozen Testes Biopsy for ICSI: The OHSU Experience.
Sexual Medicine 284 X State of Art Lecture 22 Irwin Goldstein, M.D. Industry Sponsored Phase II and III Clinical Trials in Sexual Medicine.
Tuesday, October 26, 2010        
Pediatrics - 1:35 PM - 2:30 PM          
Objectives: 1) Appraise the advantages of minimally invasive renal surgery in the pediatric population. 2) Analyze the utility of diagnostic studies for the undescended testis. 3) Review the reliability of the International Vesicoureteric Reflux grading system.
Program Planner: Tony Khoury, M.D.        
Moderators: Kourosh Afshar, M.D., Siam Oottamasathien, M.D.    
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Pediatrics 285 X   5 Mukul B. Patil, M.D. Comparison of Laparo-Endoscopic Single Site (LESS), Conventional Laparoscopic, Robotic-Assisted Laparoscopic, and Open Nephrectomy in Children 
Pediatrics 286 X   5 Jeffrey M. Woldrich, M.D. Comparison of Single Incision Laparoscopic, Conventional Laparoscopic and Open Nephrectomy in a Pediatric Population.
Pediatrics 287 X   5 Jason P. Smith, M.D. The Use of Supracostal Access During Percutaneous Nephrostolithotomy in Pediatric Patients.
Pediatrics 288 X   5 Stephen Faddegon, M.D. Determinants of Surgical Complications in Pediatric Renal Transplantation.
Pediatrics 289 X   5 Antoine E. Khoury, M.D. Improved Cosmetic Outcome for Feminizing Genitoplasty in the CAH Population.
Pediatrics 290 X   5 Gregory E. Tasian, M.D. Diagnostic Performance of Ultrasound in Localizing Non-Palpable Testes: A Systematic Review and Meta-Analysis.
Pediatrics 291 X   5 Charles Metcalfe,M.D. A Reliability Assessment of the International Vesicoureteric Reflux Grading System.
Pediatrics 292 X State of Art Lecture- No ppt received 8 Steven Skoog, M.D. A Quick Review of the AUA Vesicoureteral Reflux Guideline-What an Adult Urologist Needs to Know.
Wednesday, October 27, 2010        
Bladder & Urethra - 7:30 AM - 9:45 AM        
Objectives: 1) Discuss new techniques for visual identification of bladder tumors. 2) Describe the extent of lymph node dissection for bladder cancer. 3) Assess morbidity associated with robotic cystectomy.
Program Planner: Chris Amling, M.D.        
Moderators: Mark Gonzalgo, M.D., Stephen Williams, M.D.      
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Bladder & Urethra 293 X No ppt received 5 Jen-Jane Liu, M.D. Patterns of Catheterization Consults in a Teaching Institution.
Bladder & Urethra 294 X   5 Winifred Adams, M.D. Probe-Based Confocal Laser Endomicroscopy of The Urinary Tract: An Imaging Atlas>
Bladder & Urethra 295 X No ppt received 5 Pascal Zehnder, M.D. Bladder Cancer, an Unaltered Deadly Disease Over the Last Four Decades.
Bladder & Urethra 296 X   5 Anirban P. Mitra, M.D., Ph.D. Combination of Molecular Alterations Predict Bladder Cancer Outcome Independent of Standard Prognostic Criteria and Carcinogen Exposure.
Bladder & Urethra 297 X   5 Donald L. Lamm, M.D. 3 Week Maintenance BCG is Necessary for Optimal Prevention of Recurrence, Progression, Metastasis and Mortality in Ta, T1 and in situ Bladder Cancer.
Bladder & Urethra 298 X   5 Siamak Daneshmand, M.D. Staging Muscle Invasive Bladder Cancer with Dynamic Gadolinium Enhanced Magnetic Resonance Imaging.
Bladder & Urethra 299 X   5 Adam C. Reese, M.D. Predicting the Extent of Lymphadenectomy During Radical Cystectomy for Bladder Cancer.
Bladder & Urethra 300 X   5 Ryan P. Dorin, M.D. Incidence of Lymph Node Metastases Above the Iliac Bifurcation in Patients Undergoing Radical Cystectomy With Extended Lymph Node Dissection.
Bladder & Urethra 301 X   5 Pascal Zehnder, M.D. Patients With Unexpected Lymph Node Positive Bladder Cancer: Outcome With Radical Cystectomy and Extended Lymphadenectomy Alone.
Bladder & Urethra 302 X   5 Pascal Zehnder, M.D. Prognostic Impact of Tumor Multifocality in Patients with Urothelial Bladder Cancer Undergoing Radical Cystectomy.
Bladder & Urethra 303 X   5 Clayton Lau, M.D. Defining Early Morbidity of Robotic Assisted Radical Cystectomy Using A Standardized Reporting Methodology.
Bladder & Urethra 304 X No ppt received 5 Chris M. Whelan, M.D. Continence Outcomes Following Robotic Assisted Cystectomy with Orthotopic Neobladder Urinary Diversion.
Bladder & Urethra 305 X   5 Brian Winters, B.S.* The Impact of Intestinal Urinary Diversion on Renal Function.
Bladder & Urethra 306 X   5 Alex K. Wu, M.D. National Incidence and Outcomes of Post-Operative Urinary Retention in the Surgical Care Improvement Project.
Bladder & Urethra 307 X State of Art Lecture 23 Siamak Daneshmand, M.D. Update on Urinary Diversion Options after Radical Cystectomy.
Wednesday, October 27, 2010        
Prostate 1 - 10:30 AM - 12:00 PM          
Objectives: 1) Explain factors relating to urinary continence. 2) Appraise factors of how experience relates to improving radical prostatectomy outcomes. 3) Review take home ideas for changing surgical techniques to improve urinary continence, erectile function and continence control.
Program Planner: Herb Ruckle, M.D.        
Moderators: Chris Porter, M.D., Robert Myers, M.D.      
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Prostate 1 308 X   5 Heather Willis, M.D. Is There an Association Between Post-Training Surgical Experience in Radical Prostatectomy and Patient Outcomes?
Prostate 1 309 X Powerpoint-9/10 5 Thomas Ahlering, M.D. Impact of Short Term Regional Hypothermia on Continence and Potency Following Robot-Assisted Radical Prostatectomy.
Prostate 1 310 X   5 Jennifer L. Gurski, M.D. Neourethral Anatomy in Continent Males after Radical Prostatectomy: An Analysis with Dynamic MRI.
Prostate 1 311 X   5 Matthew R. Cooperberg, MD, MPH Quality of Life After Robot Assisted Compared to Open Radical Prostatectomy: Initial Experience in the Community Setting.
Prostate 1 312 X State of the Art Lecture- A/V NOTE: Will need to use his own computer 35 Robert P. Myers, M.D. Surgical Anatomy of the Prostate and Pelvic Floor for Efficiency & Precision in Performance of Radical Prostatectomy : Critical points for Achieving Trifecta Outcomes of Oncologic Safety, Urinary Control & Erectile Function 
Prostate 1 313 X   5 Rafael Nuñez-Nateras, M.D. A Randomized Comparison of Continence Rates After RARP: Posterior Reconstruction Versus Standard Van Velthoven Anastomosis.
Prostate 1 314 X   5 Chris M. Whelan, M.D Continence Outcomes for Technique Modification of Robotic-Assisted Laparoscopic Radical Prostatectomy.
Prostate 1 315 X   5 Brian K. Auge, M.D. Intraocular Pressures During Robotic Assisted Laparoscopic Procedures Utilizing Steep Trendelenburg Positioning.
Wednesday, October 27, 2010        
Calculi - 1:45 PM - 2:30 PM          
Objectives: 1) Describe the role of caloric intake on stone risk in females and be able to discern the possible new role of animal models for determining stone pathogenesis. 2) Appraise treatments for calculi, including medical expulsive therapies and the new generation of hand-held lithotrites and their relative merits and differing efficiencies. 3) Recognize the changing nature of stone treatments over the past decade and assess the radiation risks of CT evaluation and different CT techniques.
Program Planner: Mitchell Humphreys, M.D.      
Moderators: Mike Nguyen, M.D., Michael Moran, M.D.      
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Calculi 316 X 1st Place MBW Essay- No ppt received 5 Thomas Chi, M.D. A Novel Animal Model for Studying Urinary Stone Formation Using Drosophila Melanogaster.
Calculi 317 X   5 Ben H. Chew, M.D. Interim Analysis of a Multi-Centre Randomized Controlled Trial Comparing Three Different Modalities of Newer Lithotrites for Intracorporeal Lithotripsy.
Calculi 318 X   5 Christopher F Tenggardjaja, M.D. Low and Conventional Dose CT Scan Accurately Predict Ureteral Stone Size.
Calculi 319 X State of Art Lecture- No ppt received 10 Marshall Stoller, M.D. Systemic Manifestations Stone Disease.
Calculi 320 X No ppt received 5 Thomas Chi, M.D. Total Caloric Intake Modulates Risk for Urinary Stones in Women: Results From the Women's Health Initiative.
Calculi 321 X   5 Sean P. Stroup, M.D. Prospective Multi-Institutional Randomized Trial of Medical Expulsion Therapy for Ureterolithiasis.
Calculi 322 X   5 Caroline Colangelo, M.D. Regionalization and Practice Patterns for Inpatient Renal Stone Surgery in U.S.: Trends Over Ten Years (1998-2007).
Thursday, October 28, 2010        
Special Talks - 9:15 AM - 9:45 AM        
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
AUA Presidential Address 323 X   14 Datta G. Wagle, M.D., FACS AUA Presidential Address - USA and the AUA Perspective Role of PSA in Prostate Cancer.
WSAUA Presidential Address 324 X   4 Fred E. Govier, M.D. State of the WSAUA
AUA Foundation Talk 325 X   5 Daniel Nachtsheim, M.D. Update on AUA Foundation Activities
AUA Update 326 X   8 Richard Pelman, M.D. AUA Committee on Male Health - 2010 White Paper.
Thursday, October 28, 2010        
Kidney & Laparoscopy - 10:30 AM - 12:15 PM      
Objectives: 1) Discuss the different approaches to renal masses, including ablation and partial nephrectomy and contrast the differences in renal function, economic impact and analogical outcomes. 2) Summarize the current role of robotics and HIFU in renal surgery. 3) Critically analyze NOTES and LESS techniques for donor nephrectomies and recognize the modern challenges of multiple renal arteries in contemporary living related kidney donors.
Program Planner: Mitchell Humphreys, M.D.      
Moderators: Benjamin Chung, M.D., Blake Hamilton, M.D.      
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Kidney & Lap  327 X   5 Phil Wise, M.D. A Comparison Study of the Radiation Dose of a Two Slice CT Scanner with 64 Slice Scanners.
Kidney & Lap 328 X   5 Conrad Maciejewski, M.D. Renal Function Outcomes Following Radical and Partial Nephrectomy: Early Results From The Alberta Urology Institute Radical Nephrectomy Database.
Kidney & Lap 329 X   5 Benjamin I. Chung, M.D. Economic and Outcome Analysis of Radical versus Partial Nephrectomy for the Management of Stage T1a Renal Masses.
Kidney & Lap 330 X   5 Alan So, M.D. The Prognostic Significance of a Positive Renal Vein Resection  Margin in Patients with Renal Cell Carcinoma.
Kidney & Lap 331 X 2nd Place MBW Essay.1st author unable to attend. 5 John T. Leppert Kidney Cancer Outcomes in the VA Health Care System: Analysis of 12,112 patients from the VA Central Cancer Registry.
Kidney & Lap 332 X No ppt received 5 James Porter, M.D. 100 Robotic Partial Nephrectomies: Transperitoneal VS. Retroperitoneal Approach.
Kidney & Lap 333 X State of Art Lecture- No ppt received 15 Duane Baldwin, M.D. Laparoscopic Renal Surgery: Learning From The Past To Improve The Future.
Kidney & Lap 334 X   5 Mark D. Tyson M.D. Living Donor Kidney Transplantation with Multiple Renal Arteries in the Laparoscopic Era.
Kidney & Lap 335 X   5 Anup Shah, M.D. High Intensity Focused Ultrasound –  A New Therapeutic Modality For Laparoscopic Partial Nephrectomy
Kidney & Lap 336 X   5 Gideon D. Richards, M.D. Transureteral NOTES Nephrectomy: A Feasability Study in the Porcine Model.
Kidney & Lap 337 X   5 Andre K. Berger, M.D. Laparoendoscopic Single-Site (LESS) Donor Nephrectomy: Multi-Institutional Experience of 42 Cases.
Kidney & Lap 338 X   5 Bryan Voelzke, M.D. Contemporary Trends in the Surgical Management of Renal Trauma from a National Database.
Kidney & Lap 339 X   5 R. James Yu, M.D. Upper Tract Urothelial Carcinoma Characteristics and Survival in 1492 Patients: Data From The Veterans Affairs Central Cancer Registry (VACCR).
Kidney & Lap 340 X   5 George L. Martin, M.D. Validating the Portable Laparoscopic Trainer: A Randomized Trial of the Portable versus Standardized Laparascopic Trainer.
Thursday, October 28, 2010        
State of the Art Lectures - 1:35 PM - 2:00 PM      
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
IVU Update 341 X   5 Winifred Adams, M.D. IVU Experience Update
State of the Art Lecture 342 X   20 Andrew C. Peterson, M.D., FACS, LTC, MC Urologic Trauma, Lessons From Military Action in the 21st Century.
Thursday, October 28, 2010        
History Essay Presentations - 2:00 PM - 2:30 PM      
Objectives: 1) Discuss historical urological value to our attendees.  
Moderators: John Prince, M.D., Scott Swanson, M.D.      
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
History Essay Presentations 343 X 1st Place 5 Gregory Adams, M.D. Circumcision in the Early Christian Church.
History Essay Presentations 344 X 2nd Place 5 Phillip Mucksavage, M.D. A History and Evolution of Laparoscopic Nephrectomy: Perspectives from the Past, Current Status, and Future Directions.
History Essay Presentations 345 X 3rd Place 5 Michael E. Moran, M.D. Paleolithology.
History Essay Presentations 346 X 4th Place 5 Roger L. Sur, M.D. History of Evidence-Based Medicine.
Friday, October 29, 2010        
Prostate 2 - 7:30 AM - 10:00 AM          
Objectives: 1) Identify objective and subjective differences between open and robotic prostatectomy. 2) Discuss risk stratification and diagnostic techniques for prostate cancer. 3) Assess suitable candidates for active surveillance.
Program Planner: Herb Ruckle, M.D.        
Moderators: Joseph Presti, Jr., M.D., James L'Esperance, M.D.    
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Prostate 2 347 X   5 Miranda J. Hardee, M.D. Assessment Of The Incidence Of Fluoroquinilone Resistant Infections After Transrectal Ultrasound-Guided Biopsy With Single-Dose Antibiotic Prophylaxis.
Prostate 2 348 X   5 Peter Black, M.D. Prostate Biopsy Antisepsis Clinical Trial: A Preliminary Report.
Prostate 2 349 X   5 Stephen Lukasewycz, M.D. Clinical Outcomes After Transperineal Template-guided Prostate Biopsy.
Prostate 2 350 X   5 Chris M. Whelan, M.D The Influence of PSA Yield on the Analysis of Expressed Prostatic Secretions for Prostate Cancer Diagnosis.
Prostate 2 351 X   5 Dan Mercola, M.D., Ph.D. Diagnosis of Prostate Cancer Using Differentially Expressed Gene in Stroma.
Prostate 2 352 X   5 Adam C. Reese, M.D. Outcomes of Active Surveillance for Early Stage Prostate Cancer.
Prostate 2 353 X   5 Alex K. Wu, M.D. Utility of PCA3 in Patients Undergoing Repeat Biopsy for Prostate Cancer.
Prostate 2 354 X   5 Jennifer Linehan, M.D. Impact of Positive Surgical Margins on Biochemical Free Survival on Patients Undergoing Robotic Assisted Laparoscopic Prostatectomy.
Prostate 2 355 X   5 Rafael Nuñez-Nateras M.D. The Changing Pattern of Benign Prostate Hyperplasia Management at a Tertiary Care Center.
Prostate 2 356 X   5 Joseph M. Gleason, M.D. Osteoporosis Management Program Decreases the Incidence of Hip Fractures in Patients with Prostate Cancer on Androgen Suppression.
Prostate 2 357 X Point/CounterPoint- No ppt received 35 Robert Myers, MD / James Porter, MD. Open versus Robotic Radical Prostatectomy.
Prostate 2 358 X   5 Jen-Jane Liu, M.D. The Myth Surrounding High Grade Prostate Cancer and Small Prostates.
Prostate 2 359 X   5 Adam C. Reese, M.D. The Percent of Higher-Grade Cancer is Strongly Associated with Biochemical Prostate Cancer Recurrence After Radical Prostatectomy in Men with Gleason 7 Disease.
Prostate 2 360 X No ppt received 5 Sean Stroup, M.D. Presence of Gleason Pattern 5 on Biopsy: Subclassification of High Risk Patients From the SEARCH Database.
Prostate 2 361 X   5 Dan Lewinshtein, M.D. Prostate Cancer-Specific Survival Thirty Years After Radical Prostatectomy.
Friday, October 29, 2010        
Round Table Program - 10:10 AM - 1:00 PM      
Objectives: 1) Apply at least one new technique for the treatment of urologic disease. 2) Have fun learning the new technique(s).
Program Planners: John M. Barry, M.D., John C. Prince, M.D.    
Moderators: John C. Prince, M.D., Thomas Hefty, M.D.      
Judges: Fred Govier, M.D., Martin L. Dresner, M.D., Datta Wagle, M.D.  
SESSION Pres.# ACCEPT COMMENTS MIN. PRESENTER PAPER TITLE
Round Table Program 362 X   3 Gwen M. Grimsby, M.D. One Nut At A Time.
Round Table Program 363 X   3 William H. Tu, M.D. Gangrenous Extremities.
Round Table Program 364 X   3 Patrick S. McDonough, M.D. Sack VAC Attack
Round Table Program 365 X   3 Chasta-Dawne L. Bacsu, M.D A Painless Penile Mass in an 18 Year Old Male: A Rare Case of Fibromatosis.
Round Table Program 366 X   3 Gene O. Huang, M.D. Tap Out.
Round Table Program 367 X   3 Jonathan N. Warner, M.D. The Blue Collar Orchiectomy: A Novel Technique For The Working Man.
Round Table Program 368 X   3 Maurice M. Garcia, M.D. A Proposed Method to Improve Urethral Surveillance Cytology following Radical Cystectomy Using a Novel Modified Catheter: The Selective Urethral Wash.
Round Table Program 369 X   3 Leah Nakamura, M.D. Starting a Chain Reaction by Accessorizing Your Urethra.
Round Table Program 370 X   3 Chester J. Koh, M.D. Neonatal Genital Prolapse and Treatment Algorithm.
Round Table Program 371 X   3 Robert Laciak, M.D. What Happens in Vegas...
Round Table Program 372 X   3 Chester J. Koh, M.D. Isolated Clitoral Ectopia - First Description.
Round Table Program 373 X   3 Gideon D. Richards, M.D. In-Series Urinary Catheter Drainage Collection System: Allocation of Resources with Unlimited Potential.
Round Table Program 374 X   3 Maurice M. Garcia, M.D., MAS Do We Really Understand How Foley Catheters Work? How They Should And Should Never Be Used. (DVD submission)
Round Table Program 375 X   3 Michael E. Moran, M.D. Solving the Potential Problems with a Running Vesicourethral Anastomosis.
Round Table Program 376 X   3 Sarah D. Blaschko, M.D. A Combined Method of Bladder Neck Closure and Concomitant Augmentation Cystoplasty in the Setting of Refractory Urinary Incontinence.
Round Table Program 377 X   3 Thomas V. Vandergast, M.D. " Bag in a Bag" New and Old Fashion of a Scrotal Cystocele
Round Table Program 378 X   3 Gene O. Huang, M.D. MacGyver's Light Cord Adaptor.
Round Table Program 379 X   3 Kathleen C. Kobashi, M.D. Plugs and Slugs and Slings and Things: Innovative Ways to Fix a Leak.
Round Table Program 380 X   3 Ryan P. Kopp, M.D. Bladder Perforation Associated With Hot Tub.
Round Table Program 381 X   3 Alan R. Hay, M.D. Schistosomiasis in an American-Born Traveler: A Case Report.
Round Table Program 382 X   3 Ryan J. Bowman, M.D. Fluoroless Ureteral Stent Placement – Trick of the Trade.
Round Table Program 383 X No ppt received 3 Alex Kavanagh, M.D. Pelvic Dural Ectasia. A Rare Cause of Bilateral Ureteric Obstruction in the Pediatric Patient.
Round Table Program 384 X   3 Gautum Agarwal, M.D. Hand-Assisted Extracorporeal Laser Pedal(HELP).
Round Table Program 385 X   3 Sarah D. Blaschko, M.D. Ureteral Valves in Child with Unilateral Staghorn Renal Calculus.
Round Table Program 386 X   3 Siamak Daneshmand, M.D. Are Those Kidney Stones in Your Pocket?
Round Table Program 387 X   3 CPT. Timothy J Tausch MD, MC, USA R.A.T. P.O.I.S.O.N! Recognizing and treating patients overdosing by ingestion of superwarfarins... oh no!
Round Table Program 388 X   3 Michael E. Moran, M.D. Adrenal Oncocytoma.